3Jean CE,Jan F,Tess G.et al.Safe blood and blood products.WHO/GPA/CNP/93.2.
4Drosten C,Seifried E,Roth WK.Taqman 5'-nulease human immunodeficiency virus tape 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening[J].J Clin Microbiol,2001,39(12):4302-4308.
5David S,Peter P,John D.Combination assay detecting both human immunodeficiency virus(HIV) P24 antigen and antibodies open a second diagnostic window[J].J Clin Microbiol,2005,43(10):5397-5399.
6Bernard W,Lutz G,Rigmor T,et al.Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity[J].J Clin Microbiol,2002,40(6):1938-1946.
7Busch MP,Glynn SA,Stramer SL,et al. A new strategy for estima- ting risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion, 2005,45 ( 2 ) : 254-264.
8Centers for Disease contrnl . 2001. Revised Guidelines fir HIV Counseling Testing,and Referral and Revised Recommendations for lrtlV Screening of Pregnant Women-United States, Morbid. Mortal. Weekly Rep. 50 : RR-19.
9Fiebig, EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, L. Peddada, C. Heldebrant, R. Smith, A. Conrad, S. H. Kleinman, and M. P. Busch. 2003. Dynamics of HIV viremia and antibody serocon- version in plasma donors: implications for diat,mosis and staging of primary H1V infection. AIDS. 17 : 1871-1879.
